LAMEA Cough Remedies Market by Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, and Antibiotics), by Dosage Form (Oral Syrups, Tablets/Pills, Nasal Drops, and Lozenges), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Supermarkets/Hypermarkets, and e-Commerce/Online Pharmacies) - Opportunity Analysis and Industry Forecast, 2018-2025

Get 20% Free Customization In This Report

Healthcare	LI_183626	Pages: NA	Mar 2019 \| 1199 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Cough is a reflex action that clears the throat from fluids, irritants, foreign particles, and microbes. It is majorly caused by virus or bacteria, smoking, asthma, and other factors. Cough drops and suppressants are majorly given to the patient to cure cough. Sometimes, the patient is also advised to drink plenty of water, as a measure for cough remedy.

Increase in geriatric population, who are more prone to cough and cold, rise in vehicle pollution, high demand of over-the-counter products, development in R&D activities, and growth in awareness about advanced medicines drive the market. However, stringent government regulations and side effects associated with it restrain the market growth. More number of cough cases, development of advanced products, such as use of effective treatments (inhaled corticosteroids for asthma-related cough) make way for lucrative growth opportunities for the market.

The cough remedies market is segmented on the basis of type, dosage form, distribution network, and country. Based on type, the market is divided into antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and others. On the basis of dosage form, the market is categorized into oral syrups, tablets/pills, nasal drops, lozenges, and others. On the basis of end user, the market is classified into hospital pharmacies, retail pharmacies, drug stores, supermarkets/hypermarkets, and e-commerce/online pharmacies. By country, it is analyzed across Brazil, Saudi Arabia, South Africa, and rest of LAMEA.

The key players operating in this market include Johnson & Johnson, Reckitt Benckiser Group plc, Bayer AG, GlaxoSmithKline plc., AstraZeneca, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis AG, Prestige Brands, Inc., and Procter & Gamble.

Key Benefits

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
The report provides information about the current and upcoming trends in the market from 2016 to 2023, which helps determine the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a regional scale are provided.
Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the market.

LAMEA Cough Remedies Market Key Segments:

By Type

Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others

By Dosage Form

Oral Syrups
Tablets/Pills
Nasal Drops
Lozenges
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Supermarkets/Hypermarkets
e-Commerce/Online Pharmacies

By Country

Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTER’S FIVE FORCES ANALYSIS
3.4. MARKET DYNAMICS

3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

Chapter: 4 LAMEA COUGH REMEDIES MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ANTIHISTAMINES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. EXPECTORANTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. BRONCHODILATORS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. DECONGESTANTS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. ANTIBIOTICS

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. OTHERS

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

Chapter: 5 LAMEA COUGH REMEDIES MARKET, BY DOSAGE FORM

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ORAL SYRUPS

5.2.1. Market size and forecast

5.3. TABLETS/PILLS

5.3.1. Market size and forecast

5.4. NASAL DROPS

5.4.1. Market size and forecast

5.5. LOZENGES

5.5.1. Market size and forecast

5.6. OTHERS

5.6.1. Market size and forecast

Chapter: 6 LAMEA COUGH REMEDIES MARKET, BY DISTRIBUTION CHANNEL

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITAL PHARMACIES

6.2.1. Market size and forecast

6.3. RETAIL PHARMACIES

6.3.1. Market size and forecast

6.4. DRUG STORES

6.4.1. Market size and forecast

6.5. SUPERMARKETS/HYPERMARKETS

6.5.1. Market size and forecast

6.6. E-COMMERCE/ONLINE PHARMACIES

6.6.1. Market size and forecast

Chapter: 7 LAMEA COUGH REMEDIES MARKET, BY COUNTRY

7.1. OVERVIEW
7.2. KEY MARKET TRENDS
7.3. KEY GROWTH FACTORS AND OPPORTUNITIES
7.4. MARKET SIZE AND FORECAST

7.4.1. Brazil market size and forecast
7.4.2. Saudi Arabia market size and forecast
7.4.3. South Africa market size and forecast
7.4.4. Rest of LAMEA market size and forecast

Chapter: 8 COMPANY PROFILES

8.1. JOHNSON & JOHNSON

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. RECKITT BENCKISER GROUP PLC

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. BAYER AG

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. GLAXOSMITHKLINE PLC.

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. ASTRAZENECA

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. PFIZER INC.

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. SUN PHARMACEUTICAL INDUSTRIES LTD.

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. NOVARTIS AG

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. PRESTIGE BRANDS, INC.

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. PROCTER & GAMBLE

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

LAMEA Cough Remedies Market Key Segments:

By Type

By Dosage Form

By Distribution Channel

By Country

PURCHASE OPTIONS

Reach out to us

Request TOC/Sample

Request Customization

Request TOC/Sample

Why Allied Market Research

Infallible Methodology

Analyst Support

Customization

TARGETED MARKET VIEW

Featured Reports

Featured Readings

Get Fresh content delivered

About

Contact Us

Find Help

Get notification about our new releases

Our Products & Services

CONNECT WITH US

Press Media

We Accept